ROSG Related Momentum Movers
-
Traders Jump on Gene Plays (ROSG) (GENE) on Angelina Jolie Mastectomy News
-
Rosetta Genomics (ROSG) Sees Mid-Day Upside
-
Rosetta Genomics (ROSG) Shares Active Early on Volume
-
Rosetta Genomics (ROSG) Continues Higher on Positive Analyst Coverage, Strong Cash Position
-
UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% Upside
-
Rosetta Genomics (ROSG) Rips Higher
-
Genetic Tech (GENE), Rosetta (ROSG), Pacific Biosciences (PACB) Follow Complete Genomics (GNOM) Higher
-
Rosetta Genomics (ROSG) Pops on New Patent for Liver Cancer
-
Rosetta Genomics (ROSG) is On the Move
-
UPDATE: Rosetta Genomics (ROSG) Files to Offer Up to $35M in Shares
-
Rosetta Genomics (ROSG) Pays Off Secured Loan, Reclaims Unencumbered Rights to Assets
-
Traders 'Smell' Rosetta Genomics (ROSG) Secondary
-
Traders Witness Possible Short Squeezes in ROSG and OSIR
-
Genetic Tech. (GENE), Complete Genomics (GNOM) See Profit-Taking Following Positive Cancer Report
-
Rosetta (ROSG), Complete Genome (GNOM) Shares Surge as Study Finds Genome Sequencing Could Give Early Hints to Disease (GENE)
-
Rosetta Genomics (ROSG) Keeps Momentum Going, Indicated Much Higher Early
-
Rosetta Genomics (ROSG) Announces Validation Study Published
-
Rossetta Genomics (ROSG) Sells 570K Shares at $11.50/Sh
-
Rosetta Genomics (ROSG) Names New CFO
-
When Will Rosetta Genomics (ROSG) Crash From its 1346% Gain?
-
Rosetta Genomics (ROSG) Continues Recent Surge
-
Rosetta Genomics (ROSG) trading halted on circuit breaker, shares up 170%
Back to ROSG Stock Lookup
